Delivery Order SPE2DR25D2206-SPE2DR26F9AS8
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,302.58 to supply Spikevax 2025-26 vaccine (6M-11Y) in 0.25ML syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,087.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5 mL syringes, with an ultimate completion date of November 20, 2025. This non-set-aside competitive award was issued on October 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,353.95 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (6 months to 11 years, 0.25 mL syringes) on November 7, 2025, with completion required by December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes in the amount of $1,302.58. The order was competitively awarded without a set-aside designation and is scheduled for completion by November 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $6,512.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Spikevax 2025-26 vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 26, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of SPIKEVAX 2025-26 pediatric vaccine (6 months to 11 years) in 0.25 milliliter syringes. Valued at $2,390.04 with firm fixed pricing, this non-set-aside competitive award is scheduled for completion by November 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this order as the place of performance location, leveraging its established role...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) SYR 0.25ML vaccine product valued at $6,305.30, with an ultimate completion date of November 20, 2025. This non-set-aside, competitively awarded contract is a firm fixed price delivery order executed under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.65 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,907.74 on September 23, 2025, for the supply of Spikevax 2025-26 pediatric vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, issued under a non-competitive award mechanism. The contract is performed at the contractor's location in Conshohocken,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9AS8Delivery Order
The Defense Logistics Agency awarded a $12,610.60 delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.25 mL syringes for ages 6-11) with a completion deadline of December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA for a wide range of pharmaceutical products, medical devices, and vaccines across multiple therapeutic domains. This vaccine delivery order reflects the company's ongoing role in supporting Department of Defense immunization programs and demonstrates its capability to fulfill federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 11/7/25 |